KR100385366B1 - 생체이용율을 개선한 실리마린 제제 조성물 - Google Patents
생체이용율을 개선한 실리마린 제제 조성물 Download PDFInfo
- Publication number
- KR100385366B1 KR100385366B1 KR10-2001-0011235A KR20010011235A KR100385366B1 KR 100385366 B1 KR100385366 B1 KR 100385366B1 KR 20010011235 A KR20010011235 A KR 20010011235A KR 100385366 B1 KR100385366 B1 KR 100385366B1
- Authority
- KR
- South Korea
- Prior art keywords
- silymarin
- bioavailability
- formulation
- tromethamine
- increased
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Abstract
Description
pH1.2 | pH4.0 | pH6.8 | 물 | ||
2시간 용출율(%) | 기존 제제(A) | 19.6±1.5 | 15.8±1.8 | 43.3±2.3 | 23.5±0.4 |
신규 제제(B) | 48.8±1.2 | 57.0±5.0 | 77.7±1.8 | 100.8±2.0 | |
용출율 비율(B/A) | 2.5 | 3.6 | 1.8 | 4.3 |
AUC(㎍·min/mL) | Cmax(㎍/mL) | Tmax(min) | |
기존제제 | 2211.8±588.7 | 9.1±3.7 | 93.3±23.6 |
신규제제 | 2912.5±651.7 | 23.8±7.7 | 36.7±13.2 |
Claims (5)
- 난용성 물질인 실리마린의 생체 이용율을 증가시키기 위하여 체내 흡수 촉진제로 트로메타민을 실리마린에 대하여 1:0.5 내지 1:2 중량비로 혼합하는 것을 특징으로 하는 생체 이용율이 증가된 실리마린 제제 조성물.
- 제 1항에 있어서, 실리마린과 트로메타민의 배합비율이 1:1 중량비 임을 특징으로 하는 생체 이용율이 증가된 실리마린 제제 조성물.
- 제 1항 또는 제 2항에 있어서, 실리마린과 트로메타민의 혼합물에 폴록사머 407을 0.05-5중량% 혼합한 다음 95% 에탄올로 용해하고 40℃이하에서 감압 건조하여 제조하는 것임을 특징으로 하는 생체 이용율이 증가된 실리마린 제제 조성물.
- 제 3항에 있어서, 폴록사머 407 대신 황산라우릴나트륨을 0.01-1.0중량% 혼합하는 것을 특징으로 하는 생체 이용율이 증가된 실리마린 제제 조성물.
- 제 1항 또는 제 2항에 있어서, 실리마린 제제의 제형이 경질 캅셀제인 것을 특징으로 하는 생체 이용율이 증가된 실리마린 제제 조성물.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0011235A KR100385366B1 (ko) | 2001-03-05 | 2001-03-05 | 생체이용율을 개선한 실리마린 제제 조성물 |
PCT/KR2002/000291 WO2002069962A1 (en) | 2001-03-05 | 2002-02-25 | Compositions and preparations of silymarin complex with the improved bioavailability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0011235A KR100385366B1 (ko) | 2001-03-05 | 2001-03-05 | 생체이용율을 개선한 실리마린 제제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020071235A KR20020071235A (ko) | 2002-09-12 |
KR100385366B1 true KR100385366B1 (ko) | 2003-05-27 |
Family
ID=19706477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0011235A KR100385366B1 (ko) | 2001-03-05 | 2001-03-05 | 생체이용율을 개선한 실리마린 제제 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100385366B1 (ko) |
WO (1) | WO2002069962A1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100385366B1 (ko) * | 2001-03-05 | 2003-05-27 | 부광약품 주식회사 | 생체이용율을 개선한 실리마린 제제 조성물 |
CN113197877B (zh) * | 2021-04-02 | 2022-11-11 | 海南普利制药股份有限公司 | 包含水飞蓟素的药物组合物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994925A (en) * | 1973-01-19 | 1976-11-30 | Dr. Madaus & Co. | Salt of the silymarin group with aminopolyhydroxy alcohols |
US4061765A (en) * | 1973-01-19 | 1977-12-06 | Dr. Madaus & Co. | Polyhydroxyphenylchromanone salts and therapeutic composition |
KR0138574B1 (ko) * | 1994-10-25 | 1998-05-15 | 김용옥 | 실리마린(Silymarin)의 용해방법 |
WO1999018985A1 (de) * | 1997-10-08 | 1999-04-22 | Willmar Schwabe Gmbh & Co. | Flavonolignan-zubereitungen, insbesondere silymarin-zubereitungen |
WO2002069962A1 (en) * | 2001-03-05 | 2002-09-12 | Bukwang Pharmaceutical Company Ltd. | Compositions and preparations of silymarin complex with the improved bioavailability |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4028772A (en) * | 1971-04-02 | 1973-09-27 | Merck & Co., Inc | Chemical processes |
IT1215291B (it) * | 1985-07-17 | 1990-01-31 | Inverni Della Beffa Spa | Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche. |
EP0293259A3 (en) * | 1987-05-29 | 1990-03-07 | Kabushiki Kaisha Toshiba | Voice recognition system used in telephone apparatus |
DE19501266A1 (de) * | 1995-01-18 | 1996-07-25 | Madaus Ag | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln |
KR100342942B1 (ko) * | 1999-07-05 | 2002-07-02 | 민경윤 | 카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물 |
-
2001
- 2001-03-05 KR KR10-2001-0011235A patent/KR100385366B1/ko active IP Right Grant
-
2002
- 2002-02-25 WO PCT/KR2002/000291 patent/WO2002069962A1/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994925A (en) * | 1973-01-19 | 1976-11-30 | Dr. Madaus & Co. | Salt of the silymarin group with aminopolyhydroxy alcohols |
US4061765A (en) * | 1973-01-19 | 1977-12-06 | Dr. Madaus & Co. | Polyhydroxyphenylchromanone salts and therapeutic composition |
KR0138574B1 (ko) * | 1994-10-25 | 1998-05-15 | 김용옥 | 실리마린(Silymarin)의 용해방법 |
WO1999018985A1 (de) * | 1997-10-08 | 1999-04-22 | Willmar Schwabe Gmbh & Co. | Flavonolignan-zubereitungen, insbesondere silymarin-zubereitungen |
WO2002069962A1 (en) * | 2001-03-05 | 2002-09-12 | Bukwang Pharmaceutical Company Ltd. | Compositions and preparations of silymarin complex with the improved bioavailability |
Also Published As
Publication number | Publication date |
---|---|
KR20020071235A (ko) | 2002-09-12 |
WO2002069962A1 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20020075801A (ko) | 울혈성 심부전 치료의 부분적 지방산 산화 방지제 | |
JP3117726B2 (ja) | Vx478のようなhivプロテアーゼ阻害剤およびビタミンe―tpgsのような水溶性ビタミンeを含む組成物 | |
JP2022162149A (ja) | タクロリムスを含む徐放性薬剤学的製剤 | |
EP0277352A1 (de) | Synergistische Kombination von Azelastin und Theophyllin oder Azelastin und Beta-Mimetika | |
US20040198646A1 (en) | Menthol solutions of drugs | |
KR100385366B1 (ko) | 생체이용율을 개선한 실리마린 제제 조성물 | |
KR20090086686A (ko) | 용출율이 개선된 실리마린 함유 약학적 조성물 및 이의제조방법 | |
JP2015507006A (ja) | ユリノキの樹皮のエキスを有効成分として含有する改善された医薬製剤 | |
KR100294329B1 (ko) | 간질환 치료 및 예방용 의약 조성물 | |
CN100382799C (zh) | 一种具有保肝作用的静脉注射用粉针及其制备与质量控制方法 | |
JPH0352816A (ja) | 腎炎の治療剤 | |
US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
US6475520B1 (en) | Pharmaceutical composition with low toxicity for anti-inflammation and anti-exudation | |
KR20050075074A (ko) | 실리마린 함유 약학적 조성물 및 이를 함유하는 연질 캅셀 | |
CN111265618B (zh) | 鼓槌石斛提取物及毛兰素的医药用途 | |
US20060141028A1 (en) | Cyclosporin formulations | |
KR100791160B1 (ko) | 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물 | |
KR0178696B1 (ko) | 간보호 및 간장질환 치료용 의약조성물 | |
AU724239B2 (en) | Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS | |
JP2003160496A (ja) | グリチルリチン経口投与剤 | |
WO2021081011A1 (en) | Methods of administering cannabinoid to people diagnosed with hiv | |
US20050142204A1 (en) | Triclosan dosage form | |
KR100198490B1 (ko) | 간장질환 치료용 의약 조성물 | |
KR100472581B1 (ko) | Vx478과같은hiv프로테아제억제제및비타민e-tpgs와같은수용성비타민e화합물을포함하는조성물 | |
KR20230133029A (ko) | 톨밥탄을 포함하는 자가 유화 약물 전달 시스템 조성물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130329 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140403 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160412 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170412 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20180412 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20190327 Year of fee payment: 17 |